Peptides Studied for Mental Health & Cognition

Mental health and cognition is an area where peptide research has taken a distinctly different path in Russia than in Western countries. Selank and Semax — the two major Russian nootropic peptides — are both approved medicines in Russia, prescribed for anxiety and cognitive disorders respectively. Neither has been studied in Western clinical trials.

Selank is primarily anxiolytic, offering a fundamentally different mechanism than benzodiazepines — GABA allosteric modulation without sedation or dependence. Semax is primarily nootropic and neuroprotective, approved for ischemic stroke, cognitive disorders, and optic nerve atrophy.

The evidence for both is real but geographically concentrated. Russian regulatory approval and clinical use since 2009-2011 provides a safety signal that most research peptides lack, but the absence of Western replication means the evidence hasn't been tested against the standards that the FDA, EMA, or most Western researchers would require.